FDA
approval
· 2025-07-18
FDA Approved: EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE — Supplemental Application (Laurus Labs Limited)
Summary
The FDA approved a supplemental application for a generic fixed-dose combination emtricitabine/tenofovir disoproxil fumarate by Laurus Labs Limited for HIV-1 in…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE)